DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Kaufman B, Mackey JR, Clemens MR. et al
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.

J Clin Oncol 2009;
27 (33) 5529-5537

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: